Detalhe da pesquisa
1.
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.
Lancet Reg Health Southeast Asia;
22: 100361, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38482152